Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group (Q74602309)
Jump to navigation
Jump to search
scientific article published on 01 January 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group |
scientific article published on 01 January 1999 |
Statements
Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group (English)
B D Kahan
P R Rajagopalan
1 January 1999